@article{MAKHILLIJTM202015219988,
title = {High Performance of ELISA Using Recombinant Chikungunya Proteins for Diagnosis of
Chikungunya Fever},
journal = {International Journal of Tropical Medicine},
volume = {15},
number = {2},
pages = {11-18},
year = {2020},
issn = {1816-3319},
doi = {ijtmed.2020.11.18},
url = {https://makhillpublications.co/view-article.php?issn=1816-3319&doi=ijtmed.2020.11.18},
author = {Bo-,Sezim,Mi-,Jiro,Young,Minsun,Choi- and},
keywords = {Chikungunya Virus (CHIKV),ELISA,CHIKV E2 protein,expression system,cost-effective},
abstract = {Chikungunya fever has been emerged as a
significant public health problem in tropical and
subtropical countries. It is important to develop an
efficient and cost-effective diagnostic assay for
Chikungunya fever. The Chikungunya Virus (CHIKV) E1
and E2 proteins, the major envelope proteins of CHIKV
were expressed using Escherichia coli (E. coli) expression
system. The seroreactivity and performance of the
recombinant CHIKV E1 and E2 proteins were evaluated
in comparison with baculovirus-expressed CHIKV E2
protein using CHIKV IgM indirect Enzyme-Linked
Immunosorbent Assay (ELISA) with CHIKV-positive
specimens from Colombia, a South American
CHIKV-endemic country. The mean absorbance values of
CHIKV IgM ELISA using E. coli-expressed CHIKV E1
and E2 proteins were 0.61 and 0.73, respectively and
these were lower than baculovirus-expressed CHIKV E2
proteins (p<0.001). The sensitivities of E. coli-expressed
CHIKV E1 and E2 proteins were 90.5% (38 of 42)
and 92.9% (39 of 42) for anti-CHIKV IgM
antibodies, respectively and these were comparable
to baculovirus-expressed CHIKV E2 protein (88.1%, 37
of 42) for anti-CHIKV IgM antibodies (p = 0.50).
The E. coli-expressed recombinant CHIKV E1 and E2
proteins showed high and comparable performance
for the detection of anti-CHIKV IgM antibodies
to baculovirus-expressed CHIKV E2 protein. The
E. coli-expressed recombinant CHIKV proteins might
be a useful substitute for Chikungunya fever
diagnosis.}
}